Editors for Microbiology and Infectious Disease
Senior editors
-
Miles P Davenport
University of New South Wales, Australia
Miles Davenport is Professor of Medicine and Head of the Infection Analytics Program at the Kirby Institute for Infection and Immunity at UNSW Sydney. He graduated in medicine from the University of Sydney and completed his DPhil at the University of Oxford in immunology before retraining in mathematical biology. He leads a team of applied mathematicians who use statistical analysis and modelling to understand host-pathogen interactions in infection and immunity. This involves collaboration with a wide variety of experimental and clinical scientists both in Australian and internationally. Major areas of investigation include understanding HIV latency, malaria immunity and treatment, and neonatal immune development. He is a past-President of the Australasian Society for Immunology and is supported by an NHMRC (Australia) Investigator grant.
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Epidemiology and Global Health
- Medicine
- Research focus
- virology
- immunity
- vaccines
- HIV/AIDS
- mathematical modelling
- host-pathogen interactions
- biostatistics
- Competing interests statement
- Miles Davenport receives funding from the National Health and Medical Research Council (Australia), the Australian Research Council, and the National Institutes of Health (USA). He is an Associate Editor at PLoS Computational Biology and on the Editorial Board of Immunology and Cell Biology.
-
Wendy S Garrett
Harvard T.H. Chan School of Public Health, United States
Wendy Garrett is a Professor of Immunology and Infectious Diseases at the Harvard T. H. Chan School of Public Health, co-Director of the Harvard Chan Center for the Microbiome in Public Health, and an Associate Member of the Broad Institute. Her work explores host-microbiota interactions underlying mucosal immune homeostasis, gastrointestinal inflammatory disorders, and cancer. She graduated from the Yale College; received her MD PhD from Yale University and completed post-graduate training at Harvard.
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Medicine
- Research focus
- host-microbiota interactions
- microbiome
- mucosal immunology
- Competing interests statement
- Wendy Garrett serves on advisory boards of Evelo Biosciences, Kintai Therapeutics, and Leap Therapeutics. She is a member of the Cell Reports and Journal of Clinical Microbiology editorial boards.
-
Diane M Harper
University of Michigan, United States
Diane M Harper, MD, MPH, MS, completed her undergraduate and graduate degrees at the Massachusetts Institute of Technology in Cambridge, Massachusetts, in the fields of Chemical Engineering and Polymerics. She received her medical and public health degrees from the University of Kansas in Kansas City, where she also did residencies in Gynecology/Obstetrics and Family Medicine. Dr Harper has spent the majority of her professional career at Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, as clinician, teacher and researcher in the Departments of Obstetrics and Gynecology, Community and Family Medicine and Women’s and Gender Studies, including improving life for LGBTQ.
She has received the Society of Teachers of Family Medicine (STFM) Excellence in Education Award and the Curtis Hames Research Award honoring her for changing medical care for women through evidence based research. She served as the Chair of Family and Geriatric Medicine at the University of Louisville during which time she also served on the United States Preventive Services Task Force.
She currently is a tenured Professor at the University of Michigan, serving as the Director for Research Management within the Michigan Institute of Clinical and Health Research, one of 50 Clinical and Translational Science Award Research Hubs across the United States. To date she has over 250 peer reviewed publications with over 27,000 citations, and over 40,000 downloads of her seminal review of HPV vaccines.
While at Dartmouth she developed and directed the Gynecologic Cancer Prevention Research Group based at the Norris Cotton Cancer Center in which research on all aspects of HPV associated diseases, specifically cervical cancer prevention was conducted. She is an internationally recognized expert on Human Papillomavirus, the cause of cervical cancer, and its prophylactic and therapeutic vaccines. She has published the sentinel clinical research on HPV vaccines and lectured internationally in over 100 countries. She has served on NCI research committees, European research study sections, addressed the Council on Foreign Affairs, and served as a technical advisor to the World Health Organization. Dr Harper has been honored as one of the top clinicians in her field in the US, and Family Physician of the Year in New Hampshire in 2006.
- Expertise
- Medicine
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Immunology and Inflammation
- Research focus
- HPV associated diseases
- primary care
- women's health
- cancer precursor detection
- health behaviours
- epidemiology
- cancer screening
- Experimental organism
- human
- Competing interests statement
- Diane Harper has received funding from NCI, NCATS, NHLBI, CDC, multiple national philanthropic organizations, including the American Cancer Society, The Robert Wood Johnson Foundation, and the Susan G Komen Foundation, in addition to state and local funding agencies and collaborations with industry. She serves in editorship capacities on boards including the Annals of Family Medicine, Preventive Medicine Reports, PLoS ONE, and Gynecologic Oncology. She is a peer reviewer for The Lancet, The New England Journal of Medicine, JAMA, among other journals.
-
Bavesh Kana
University of the Witwatersrand, South Africa
Bavesh Kana directs the DSI/NRF Centre of Excellence for Biomedical TB Research, a national Centre of Excellence with nodes at University of the Witwatersrand, Stellenbosch University and the University of Cape Town. He is a research fellow at the Centre for AIDS Programme of Research in South Africa and a consultant for the South African Medical Research Council and the Bill and Melinda Gates Medical Research Institute in Cambridge, USA. He obtained his PhD at the University of the Witwatersrand, and has conducted research visits at the University of Pennsylvania, the Russian Academy of Sciences in Moscow, Texas A&M University, the Public Health Research Institute in New Jersey and Harvard Medical School. He studies tuberculosis with a focus on identifying new drug targets implicated in remodelling of the peptidoglycan layer in the cell wall of the tubercle bacteria that cause this disease. His research extends to the clinical setting in South Africa, where he has developed several cohorts to study treatment response in individuals infected with tuberculosis and HIV, with an emphasis on eradicating persister organisms and shortening treatment duration. He has also been involved in the development of proficiency and quality assurance reagents for scaled deployment of infectious disease molecular diagnostics in resource-limited settings. Among the awards he has received are an appointment as an Early Career Scientist of the Howard Hughes Medical Institute, selection as one of the 200 top young South Africans by the Mail and Guardian newspaper, the South African Medical Research Council scientific merit award for outstanding lifetime scientific contribution to health research, and the Vice Chancellors Innovation Award. He received the CEO Titan Award for meaningful contributions to shift the African landscape and has been involved in various spinout biotech companies in South Africa and internationally. He is a member of the Health Professions Council of South Africa and the Academy of Science of South Africa.
- Expertise
- Microbiology and Infectious Disease
- Research focus
- tuberculosis
- tuberculosis-HIV
- bacterial dormancy
- bacterial persistence
- differential culturability
- peptidoglycan
- bacterial cell walls
- bacterial energy metabolism
- tuberculosis drugs
- drug resistance
- Experimental organism
- M. tuberculosis
- M. smegmatis
- E. coli
- SARS-CoV-2
- Competing interests statement
- Bavesh Kana has received funding from the Howard Hughes Medical Institute, Bill and Melinda Gates Foundation, United States National Institutes of Health, European and Developing Countries Clinical Trials Partnership (EDCTP), South African Department of Science and Technology/Innovation, South African National Research Foundation, South African Medical Research Council, National Health Laboratory Services and the University of the Witwatersrand. He is a co-founder of and scientific advisor to SmartSpot Quality CC and scientific advisor to the Sydney Brenner Institute for Molecular Bioscience, Microscopy and Microanalysis Unit at the University of the Witwatersrand, Cape Town HVTN laboratory and Olilux Biosciences (USA).
-
Päivi Ojala
University of Helsinki, Finland
Imperial College London, United KingdomPäivi Ojala is the Professor of Cancer Cell Biology at University of Helsinki and Chair of Viral Tumorigenesis at Imperial College London. She has made significant contributions to the Kaposi’s Sarcoma herpesvirus (KSHV) field and has more recently focused also on the role of lymphatic endothelial microenvironment on cancer cell metastasis. She has expertise in organotypic 3D co-culture models, cell-based high-content screens, protein kinase signalling and viral technologies. Her work has led to demonstration of restoration of p53 function by small molecule inhibitors as a therapeutic modality for KSHV-induced lymphomas, identification of host Pim kinases, nucleophosmin, and the p53-p21 axis as novel regulators of viral replication, and shown that KSHV infection reprograms lymphatic endothelial cells (LECs) to a new, more invasive cell type. They have also demonstrated that LEC interaction with melanoma cells leads to increased distant organ metastasis in vivo, which is dependent on MMP14, Notch3 and b1-integrin- Dr. Ojala holds a doctoral degree in Molecular Genetics from the University of Helsinki, and has received postdoctoral training at the Yale School of Medicine, CT, USA.
- Expertise
- Cancer Biology
- Microbiology and Infectious Disease
- Research focus
- human tumor viruses
- virus-host interactions
- tumor microenvironment
- metastasis
- Competing interests statement
- Päivi Ojala receives funding from the Academy of Finland, Sigrid Juselius Foundation, Cancer Foundation Finland and University of Helsinki.
-
Sara L Sawyer
University of Colorado Boulder, United States
Sara Sawyer is a recognized expert in the birth of new human viruses deriving from animal reservoirs. Dr Sawyer has received national and international awards including the Richard M. Elliott award in virology, the Alfred P. Sloan fellowship, and the Andy Kaplan Prize in Retrovirology. In 2011 she was awarded a PECASE award from President Obama at the White House. She holds a PhD from Cornell University, a BS in Chemical Engineering, and completed postdoctoral training at the Fred Hutchinson Cancer Research Center.
Dr Sawyer is an expert in virology, evolution, model organisms, viral reservoirs, infectious disease diagnostics, and testing and monitoring in COVID-19.
- Expertise
- Microbiology and Infectious Disease
- Evolutionary Biology
- Immunology and Inflammation
- Research focus
- virology
- viral host-switching and zoonosis
- host-virus arms races
- innate immunity
- genomics
- HIV
- SARS-CoV-2
- dengue viruses
- arenaviruses
- influenza viruses
- Experimental organism
- human
- viruses
- tissue culture
- Competing interests statement
- Sara Sawyer is a co-founder of Darwin Biosciences, which develops infectious disease diagnostics. She is a consultant for the U.S. government on biomedical issues relevant to national defense. She receives funding from the National Institutes of Health, the Burroughs Wellcome Fund, and the Department of Defense.
-
Dominique Soldati-Favre
University of Geneva, Switzerland
Dr Dominique Soldati-Favre studied biochemistry and earned her PhD degree in molecular biology from the University of Zürich (Switzerland) in 1990. She then conducted postdoctoral research in the Department of Microbiology and Immunology of the Stanford University School of Medicine. In 1995 she was appointed assistant professor at the Center for Molecular Biology at the University of Heidelberg (Germany). In 2001 she moved to Imperial College London (United Kingdom) and became Reader. Since 2004, she is professor at the Faculty of Medicine of the University of Geneva.
Her laboratory is studying obligate intracellular parasitism using Toxoplasma gondii and is also increasingly engaged in malaria research. The main line of research focuses on the cell biology underlying how these pernicious pathogens glide into mammalian cells. Her group is also aiming at defining the metabolic needs and capabilities of the parasites as well as how they subvert host cellular functions in particular to access nutrients.
- Expertise
- Microbiology and Infectious Disease
- Biochemistry and Chemical Biology
- Cell Biology
- Genetics and Genomics
- Research focus
- parasitology
- organelle biogenesis
- protein trafficking
- metabolism
- host pathogen interaction
- signalling
- Experimental organism
- T. gondii
- apicomplexans
- kinetoplastids
- Competing interests statement
- Dominique Soldati-Favre currently receives funding from the European Research Council and from the Swiss National Science Foundation. She is editor for Parasitology at Molecular Microbiology and she is on the editorial boards of PLOS Pathogens, Traffic and mBio.
-
Gisela Storz
National Institute of Child Health and Human Development, United States
Gisela Storz has been an Investigator in the Eunice Kennedy Shriver Institute of Child Health and Human Development in Bethesda, Maryland since 1991. She obtained a BA in Biochemistry from the University of Colorado in 1984 and a PhD in Biochemistry from the University of California, Berkeley in 1988, where she studied the bacterial response to oxidative stress working with Bruce Ames. Her current work is focused on understanding gene regulation in response to environmental signals and elucidating the roles of small RNAs and small proteins of less than 50 amino acids in these regulatory networks. Dr. Storz was the recipient of the American Society for Microbiology Eli Lilly Award and is a member of the American Academy of Microbiology, American Academy of Arts and Sciences and US National Academy of Sciences.
- Expertise
- Microbiology and Infectious Disease
- Chromosomes and Gene Expression
- Research focus
- small noncoding RNAs
- oxidative stress
- gene regulation
- bacterial physiology
- regulatory RNAs
- Experimental organism
- E. coli
- Competing interests statement
- Gisela Storz is employed by the Intramural Program of the National Institutes of Health. She served on the Scientific Advisory Board of Max Planck Institute for Terrestrial Microbiology. In addition to being a Senior Editor for eLife, she is an Editor at RNA and on the Editorial Boards of mBio, Annual Reviews of Genetics and Microbiology Spectrum.
-
Jos WM van der Meer
Radboud University Medical Centre, Netherlands
Jos WM van der Meer is emeritus Professor of Medicine at Radboud University Nijmegen, The Netherlands. Between 1992 and 2012 he was head of the Department of internal medicine at the Radboud University Medical Centre. His major areas of expertise are host defence against infection, trained immunity, autoinflammation, immunodeficiency and antimicrobial policy.
- Expertise
- Medicine
- Microbiology and Infectious Disease
- Research focus
- infectious disease and host defense
- innate immunity
- trained immunity
- immunodeficiency
- autoinflammatory diseases
- chronic fatigue syndrome
- Experimental organism
- human
- mouse
- Competing interests statement
- Jos WM van der Meer is a member of the Royal Netherlands Academy of Arts and Sciences (KNAW), for which he served as a vice-president from 2005 to 2011. He is a member of Academia Europaea and he is past-president of EASAC, the European Academies Science Advisory Council. He is an honorary Fellow of the Royal College of Physicians in London and in Edinburgh and a fellow of the Infectious Diseases Society of America and of the European Society of Clinical Microbiology and Infectious diseases. He is a member of the Dutch National Board for Research Integrity LOWI. He received a number of prices and awards, such as the Gold Hijmans van den Bergh medal. He was awarded knighthood in the order of the Netherlands Lion in 2003.
Reviewing editors
-
Jonathan Abraham
Harvard Medical School, United States
- Expertise
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
- Microbiology and Infectious Disease
- Medicine
- Research focus
- emerging viruses
- antibody neutralisation
- viral entry
- viral replication
- x-ray crystallography
- cryo-EM
-
Sonja V Albers
University of Freiburg, Germany
- Expertise
- Microbiology and Infectious Disease
- Research focus
- molecular biology of Archaea
- Sulfolobus
- Haloferax
-
Rebecca Bart
The Donald Danforth Plant Science Center, United States
- Expertise
- Plant Biology
- Genetics and Genomics
- Microbiology and Infectious Disease
- Research focus
- host-pathogen-environment interactions
- non-model organisms
- cassava
- Xanthomonas
- genetics
- genomics
-
Christine Beemelmanns
Leibniz Institute for Natural Product Research and Infection Biology, Germany
- Expertise
- Microbiology and Infectious Disease
- Ecology
- Research focus
- microbe-host interactions
- natural products
- total synthesis
- symbiosis
- bioorganic synthesis
- sphingolipids
-
Pamela Bjorkman
California Institute of Technology, United States
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Structural Biology and Molecular Biophysics
- Research focus
- HIV
- coronavirus
- antibodies
- neutralization
- vaccine design
- viral fusion
- structural biology
-
Melanie Blokesch
École Polytechnique Fédérale de Lausanne, Switzerland
- Expertise
- Microbiology and Infectious Disease
- Research focus
- regulatory networks
- horizontal gene transfer
- secretion systems
- quorum sensing
- V. cholerae
-
Axel A Brakhage
Leibniz Institute for Natural Product Research and Infection Biology (HKI), Germany
- Expertise
- Microbiology and Infectious Disease
- Research focus
- infection biology of fungi
- microbial secondary metabolism
- microbial communication
- biotechnology
- transcription factors
- macrophages
- neutrophils
- Experimental organism
- Aspergillus
- Streptomyces
-
Melanie M Brinkmann
Technische Universität Braunschweig, Germany
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Research focus
- herpesviruses
- innate immunity
- intracellular trafficking
-
Jan E Carette
Stanford University School of Medicine, United States
- Expertise
- Microbiology and Infectious Disease
- Genetics and Genomics
- Research focus
- virology
- virus-host interactions
- AAV gene therapy
- virus entry
- viral pathogenesis
- picornaviruses
- flaviviruses
-
Jean-Laurent Casanova
The Rockefeller University, United States
- Expertise
- Genetics and Genomics
- Microbiology and Infectious Disease
- Immunology and Inflammation
- Medicine
- Research focus
- human genetics
- immunology
- infectious diseases
- primary immunodeficiency
- inborn errors of immunity
- Experimental organism
- human
-
Flaminia Catteruccia
Harvard School of Public Health, United States
- Expertise
- Microbiology and Infectious Disease
- Research focus
- vector biology
- malaria
- vector-plasmodium interactions
- reproductive biology
- Experimental organism
- A. gambiae
-
Sara Cherry
University of Pennsylvania, United States
- Expertise
- Genetics and Genomics
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Research focus
- virology
- microbiology
- innate immunity
- genetics
- genomics
- emerging pathogens
- Experimental organism
- D. melanogaster
-
Isaac Chiu
Harvard Medical School, United States
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Neuroscience
- Research focus
- neuroimmunology
- pain
- microglia
- infection
- bacterial pathogens
- Experimental organism
- mouse
- rat
-
Christine Clayton
Zentrum fuer Molekulare Biologie der Universitaet Heidelberg (ZMBH), Germany
- Expertise
- Microbiology and Infectious Disease
- Epidemiology and Global Health
- Research focus
- trypanosomes
- mRNA degradation
- RNA-binding proteins
-
Maureen L Coleman
University of Chicago, United States
- Expertise
- Microbiology and Infectious Disease
- Ecology
- Evolutionary Biology
- Research focus
- eco-microbiology
- microbial ecology
- microbial evolution
- biogeochemistry
- microbial ecosystems biology
- marine microbiology
- genomics
- cyanobacteria
- phototrophy
- bacteriophages
-
Caroline Colijn
Simon Fraser University, Canada
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Research focus
- evolution of pathogens
- pathogen ecology
- mathematics
- epidemiological modelling
-
Lydia Contreras
The University of Texas at Austin, United States
- Expertise
- Biochemistry and Chemical Biology
- Microbiology and Infectious Disease
- Research focus
- bacteria
- regulatory RNAs
- sRNAs
- bacterial regulation
- epitranscriptomics
- RNA modifications
-
Alex R Cook
National University of Singapore, Singapore
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- infectious disease epidemiology
- mathematical modelling
- biostatistics
- health policy
-
Vaughn S Cooper
University of Pittsburgh, United States
- Expertise
- Evolutionary Biology
- Microbiology and Infectious Disease
- Genetics and Genomics
- Research focus
- experimental evolution
- antimicrobial resistance
- biofilms
- education
- adaptation
- cancer
- Experimental organism
- Pseudomonas
- E. coli
- Burkholderia
- Acinetobacter
-
Laura Dassama
Stanford University, United States
- Expertise
- Biochemistry and Chemical Biology
- Microbiology and Infectious Disease
- Research focus
- bacterial multidrug resistance
- chemoenzymatic syntheses
- beta-hemoglobinopathies
-
Samuel L Díaz-Muñoz
University of California, Davis, United States
- Expertise
- Evolutionary Biology
- Genetics and Genomics
- Microbiology and Infectious Disease
- Research focus
- social evolution
- reassortment
- experimental evolution
- genomics
- sex
- environmental microbiology
- behavior
-
Nels C Elde
University of Utah, United States
- Expertise
- Evolutionary Biology
- Microbiology and Infectious Disease
- Immunology and Inflammation
- Research focus
- host-microbe interactions
- evolutionary genetics
- virus evolution
- experimental evolution
- innate immunity
- Experimental organism
- primates
- poxviruses
- zebrafish
-
Ron AM Fouchier
Erasmus Medical Center, Netherlands
- Expertise
- Microbiology and Infectious Disease
- Research focus
- influenza
- respiratory viruses
- emerging viruses
- virus evolution
-
Guangxia Gao
Institute of Biophysics, Chinese Academy of Sciences, China
- Expertise
- Microbiology and Infectious Disease
- Research focus
- retroviruses
- HIV-1
- virus-host interactions
- Experimental organism
- mouse
- viruses
-
Evangelos J Giamarellos-Bourboulis
Attikon University Hospital, Greece
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Genetics and Genomics
- Medicine
- Research focus
- sepsis
- hidradenitis suppurativa
- pathogenesis of infection
- biomarkers
-
Karine A Gibbs
Harvard University, United States
- Expertise
- Microbiology and Infectious Disease
- Biochemistry and Chemical Biology
- Research focus
- Proteus mirabilis
- sociomicrobiology
- bacterial genetics
- kin discrimination
- self/non-self recognition
-
Thomas Gingeras
Cold Spring Harbor Laboratory, United States
- Expertise
- Chromosomes and Gene Expression
- Computational and Systems Biology
- Genetics and Genomics
- Microbiology and Infectious Disease
- Research focus
- genomics
- gene expression
- regulatory networks
- chromosomal modification
- Experimental organism
- D. melanogaster
- human
- mouse
-
Frederik Graw
Heidelberg University, Germany
- Expertise
- Immunology and Inflammation
- Computational and Systems Biology
- Microbiology and Infectious Disease
- Research focus
- mathematical modelling
- theoretical immunology
- host-pathogen interactions
- viral spread
- infection dynamics
- Experimental organism
- mouse
- viruses
-
Peter Greenberg
University of Washington School of Medicine, United States
- Expertise
- Microbiology and Infectious Disease
- Research focus
- microbial physiology
- gene regulation
- sociomicrobiology
- quorum sensing
- cell-cell communication
-
Shozeb Haider
University College London, United Kingdom
- Expertise
- Medicine
- Structural Biology and Molecular Biophysics
- Computational and Systems Biology
- Microbiology and Infectious Disease
- Research focus
- X-ray crystallography
- molecular dynamics simulations
- allostery
- structure-based drug design
- structural bioinformatics
- computational chemistry
- nucleic acids
- rare diseases
-
Nicola L Harris
Monash University, Australia
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Research focus
- type 2 immunity
- helminth infection
- microbiota
- mucosal immunology
-
Sophie Helaine
Imperial College London, United Kingdom
- Expertise
- Microbiology and Infectious Disease
- Research focus
- host-pathogen interaction
- bacterial pathogenesis
- persistence
- antibiotic persisters
- toxin-antitoxin systems
- Experimental organism
- Salmonella
-
Niel Hens
University of Antwerp, Belgium
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Research focus
- multivariate statistics
- HCV and HIV coinfection
- infectious disease modelling
- applied statistics
-
Prabhat Jha
Saint Michael's Hospital, Canada
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- epidemiology
- global health
- infectious disease and population dynamics
- randomized controlled trials
-
Mark Jit
London School of Hygiene & Tropical Medicine, and Public Health England, United Kingdom
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Research focus
- vaccines
- infectious disease epidemiology
- mathematical modelling
- health economics
- low- and middle-income countries
- Experimental organism
- human
- vaccine-preventable pathogens
- human papillomavirus
- measles virus
- rotavirus
- influenza virus
- S. pneumoniae
-
Elizabeth Johnson
Cornell University, United States
- Expertise
- Microbiology and Infectious Disease
- Research focus
- gut microbiome
- sphingolipids
- infant nutrition
-
Frank Kirchhoff
Ulm University Medical Center, Germany
- Expertise
- Microbiology and Infectious Disease
- Research focus
- AIDS
- innate immunity
- restriction factors
- viral evasion
- Experimental organism
- HIV
- SIV
- SARS-CoV-2
-
Karla Kirkegaard
Stanford University School of Medicine, United States
- Expertise
- Microbiology and Infectious Disease
- Immunology and Inflammation
- Research focus
- drug resistance
- viral evolution
- dominant genes
- Experimental organism
- human
- mouse
- viruses
-
David M Knipe
Harvard Medical School, United States
- Expertise
- Microbiology and Infectious Disease
- Research focus
- DNA viruses
- epigenetic regulation
- latent infection
- innate and intrinsic immunity
- vaccines
- Experimental organism
- mouse
-
Urszula Krzych
Walter Reed Army Institute of Research, United States
- Expertise
- Epidemiology and Global Health
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Research focus
- adoptive immunity
- immune memory responses
- liver resident T memory cells
- Plasmodium liver stage infection
- Plasmodium antigens/vaccines
- design of malaria vaccines
-
Luis F Larrondo
Pontificia Universidad Católica de Chile, Chile
- Expertise
- Microbiology and Infectious Disease
- Chromosomes and Gene Expression
- Research focus
- circadian biology
- photobiology
- synthetic biology
- gene expression
- fungal biology
- plant pathogenic fungi
- filamentous fungi
- Experimental organism
- S. cerevisiae
N. crassa
-
Michael Laub
Massachusetts Institute of Technology, United States
- Expertise
- Cell Biology
- Microbiology and Infectious Disease
- Research focus
- bacterial cell cycle
- toxin-antitoxin systems
- signal transduction
- protein evolution
- chromosome organisation
- Experimental organism
- E. coli
- C. crescentus
-
Elena Levashina
Max Planck Institute for Infection Biology, Germany
- Expertise
- Microbiology and Infectious Disease
- Research focus
- malaria ecology
- mosquito immune system
- Anopheles gambiae
- Experimental organism
- P. falciparum
-
Petra Anne Levin
Washington University in St. Louis, United States
- Expertise
- Cell Biology
- Microbiology and Infectious Disease
- Research focus
- bacterial cytoskeleton
- temporal and spatial control of cell division
- cell size control
- cell cycle dynamics in bacterial systems
- Experimental organism
- B. subtilis
- E. coli
-
Joseph Lewnard
University of California, Berkeley , United States
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Research focus
- epidemiology
- infectious disease
- vaccines
- casual inference
- transmission modelling
- streptococcus spp.
- respiratory pathogens
- enteric disease
-
Wenhui Li
National Institute of Biological Sciences, China
- Expertise
- Microbiology and Infectious Disease
- Research focus
- virus infection
- hepatitis b/d virus
- receptor
- antivirals
- Experimental organism
- human
- mouse
- viruses
-
Marc Lipsitch
Harvard T.H. Chan School of Public Health, United States
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- pathogen transmission modeling
- evolution of pathogens
- vaccine epidemiology
- antimicrobial resistance
- research ethics
- Experimental organism
- S. pneumoniae
-
Sebastian Lourido
Whitehead Institute for Biomedical Research, United States
- Expertise
- Microbiology and Infectious Disease
- Cell Biology
- Genetics and Genomics
- Biochemistry and Chemical Biology
- Research focus
- calcium signaling
- host-pathogen interactions
- genetic screening
- protein kinases
- genomics
- quantitative proteomics
- Apicomplexan parasites
- Experimental organism
- T. gondii
- P. falciparum
-
Mark Marsh
University College London, United Kingdom
- Expertise
- Microbiology and Infectious Disease
- Cell Biology
- Research focus
- virus entry
- membrane trafficking
- cellular mechanisms of viral restriction
- viral pathogenesis
- HIV
- Alphaviruses
- Flaviviruses
- endocytosis
- virus receptors
- Experimental organism
- viruses
-
Malcolm J McConville
University of Melbourne, Australia
- Expertise
- Microbiology and Infectious Disease
- Biochemistry and Chemical Biology
- Research focus
- protozoan parasites
- metabolomics
- metabolism
- Leishmaniasis
- trypanosomatids
- glycobiology
- Experimental organism
- T. gondii
-
Tam Mignot
Aix-Marseille University, France
- Expertise
- Microbiology and Infectious Disease
- Physics of Living Systems
- Research focus
- signal transduction
- motility
- bacterial development
- bacterial cell biology
- Experimental organism
- M. xanthus
-
Shaeri Mukherjee
University of California, San Francisco, United States
- Expertise
- Cell Biology
- Microbiology and Infectious Disease
- Research focus
- membrane traffic
- host-pathogen interactions
- endoplasmic reticulum
- Experimental organism
- L. pneumophila
-
Phil Newmark
Morgridge Institute for Research, University of Wisconsin-Madison, United States
- Expertise
- Developmental Biology
- Microbiology and Infectious Disease
- Research focus
- Planarian
- regeneration
- Schistosoma
- germ cells
-
Thorsten Nurnberger
University of Tübingen, Germany
- Expertise
- Cell Biology
- Microbiology and Infectious Disease
- Plant Biology
- Research focus
- innate immunity
- plant-microbe interactions
- plant immunity
- Experimental organism
- A. thaliana
-
C. Brandon Ogbunugafor
Yale University, United States
- Expertise
- Computational and Systems Biology
- Evolutionary Biology
- Epidemiology and Global Health
- Physics of Living Systems
- Microbiology and Infectious Disease
- Research focus
- disease ecology
- microbial evolution
- population genetics
- epidemiology
- evolutionary medicine
- Experimental organism
- E. coli
- human
- P. falciparum
- S. cerevisiae
- viruses
-
Kim Orth
University of Texas Southwestern Medical Center, United States
- Expertise
- Biochemistry and Chemical Biology
- Cell Biology
- Microbiology and Infectious Disease
- Research focus
- Vibrio
- T3SS
- virulence pathogenesis
- host-pathogen
- AMPylation
- Fic-domain
- Experimental organism
- Vibrio spp
-
Julie Overbaugh
Fred Hutchinson Cancer Research Center, United States
- Expertise
- Microbiology and Infectious Disease
- Research focus
- HIV neutralizing antibodies
- HIV ADCC antibodies
- HIV transmission
- interferon and HIV restriction
-
Paul Rainey
Max Planck Institute for Evolutionary Biology, Germany
- Expertise
- Ecology
- Evolutionary Biology
- Microbiology and Infectious Disease
- Plant Biology
- Research focus
- adaptive radiation
- evolution of individuality
- evolutionary genetics
- ecological genetics
- emergence of infectious diseases
- forecasting evolution
-
Isabel Rodriguez-Barraquer
University of California, San Francisco, United States
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- dengue
- malaria
- Zika
- vector-bone diseases
- serology
- modeling
- Experimental organism
- human
-
Antonis Rokas
Vanderbilt University, United States
- Expertise
- Evolutionary Biology
- Microbiology and Infectious Disease
- Research focus
- phylogenomics
- genome evolution in fungi and animals
- evolution of fungal secondary/specialized metabolic pathways
- evolution of mammalian pregnancy
- eukaryotic genome evolution
- evolution of opportunistic pathogenicity
- Experimental organism
- S. cerevisiae
- mammals
- Aspergillus
-
Joshua T Schiffer
Fred Hutchinson Cancer Research Center, United States
- Expertise
- Microbiology and Infectious Disease
- Epidemiology and Global Health
- Immunology and Inflammation
- Medicine
- Research focus
- mathematical modelling
- herpesviruses
- HIV
- COVID-19
- T cell immunology
- Experimental organism
- human
- viruses
- HSV
- SARS-CoV-2
-
John W Schoggins
University of Texas Southwestern Medical Center, United States
- Expertise
- Microbiology and Infectious Disease
- Immunology and Inflammation
- Research focus
- innate immunity
- virology
- antiviral
- interferon
- Experimental organism
- human
- mouse
- bats
-
Olivier Silvie
Sorbonne Université, Inserm, France
- Expertise
- Microbiology and Infectious Disease
- Research focus
- parasite biology
- malaria
- host-parasite interactions
- vaccines
- Experimental organism
- P. falciparum
- human
- mouse
-
Viviana Simon
The Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- viral-host interactions
- retroviral restriction factors
- HIV drug resistance
-
Christina L Stallings
Washington University School of Medicine, United States
- Expertise
- Microbiology and Infectious Disease
- Immunology and Inflammation
- Chromosomes and Gene Expression
- Research focus
- bacterial pathogenesis
- mycobacterium tuberculosis
- bacterial transcription
- innate immune responses
- host-pathogen interactions
-
Margaret Stanley
University of Cambridge, United Kingdom
- Expertise
- Cancer Biology
- Microbiology and Infectious Disease
- Medicine
- Epidemiology and Global Health
- Research focus
- vaccines
- cervix cancer
- cervix precancer
- keratinocyte biology
- human papillomavirus
- DNA viruses
- vaccine immunology
- Experimental organism
- human
-
Peter Turnbaugh
University of California, San Francisco, United States
- Expertise
- Microbiology and Infectious Disease
- Research focus
- metagenomics
- human gut microbiome
- nutrition
- pharmacology
- bacteriophages
- CRISPR-Cas systems
- gnotobiotics
- microbial metabolism
- Experimental organism
- human
- mouse
-
Dario Riccardo Valenzano
Max Planck Institute for Biology of Ageing, Germany
- Expertise
- Evolutionary Biology
- Genetics and Genomics
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Research focus
- biology of aging
- microbiome
- killifish
- neutral evolution
- mutation load
- comparative genomics
- immunosenescence
-
Frank van de Veerdonk
Radboud University Medical Center, Netherlands
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Medicine
- Research focus
- medical mycology
- clinical immunology
-
Russell E Vance
University of California, Berkeley, United States
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Research focus
- innate immunity
- bacterial pathogenesis
- interferon
- inflammasomes
- pathogen-sensing
- Experimental organism
- mouse
- L. pneumophila
- M. tuberculosis
-
Kevin Verstrepen
VIB-KU Leuven Center for Microbiology, Belgium
- Expertise
- Evolutionary Biology
- Genetics and Genomics
- Microbiology and Infectious Disease
- Research focus
- yeast
- aroma
- fermentation
- genomics
- molecular evolution
- Experimental organism
- S. cerevisiae
-
Joseph T Wade
Wadsworth Center, United States
- Expertise
- Chromosomes and Gene Expression
- Genetics and Genomics
- Microbiology and Infectious Disease
- Research focus
- bacterial gene regulation
- bacterial CRISPR systems
- bacterial regulatory RNA
- Experimental organism
- E. coli
- S. typhimurium
- M. tuberculosis
-
Jacco Wallinga
National Institute for Public Health and the Environment, Netherlands
Leiden University Medical Center, Netherlands- Expertise
- Microbiology and Infectious Disease
- Epidemiology and Global Health
- Medicine
- Research focus
- modeling of infectious diseases
- vaccination
- infectious disease control
- public health
- bioinformatics
-
Amy Wesolowski
Johns Hopkins Bloomberg School of Public Health, United States
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Research focus
- infectious diseases
- mobility
- malaria
- parasites
- measles
-
Alexander Westermann
Helmholtz Centre for Infection Research, Germany, Germany
- Expertise
- Microbiology and Infectious Disease
- Research focus
- Dual RNA-seq
- small RNA
- bacteroides thetaiotaomicron
- ProQ
-
Blake Wiedenheft
Montana State University, United States
- Expertise
- Chromosomes and Gene Expression
- Microbiology and Infectious Disease
- Research focus
- bacteriophages
- genome editing
- host-parasite interactions
-
Karina B Xavier
Instituto Gulbenkian de Ciência, Portugal
- Expertise
- Microbiology and Infectious Disease
- Research focus
- bacterial signal transduction
- quorum sensing
- microbiota
- microbe-host interactions
- symbiosis
- gene regulation
- bacterial metabolism
- Experimental organism
- mouse
- E. coli
-
Jie Xiao
Johns Hopkins University, United States
- Expertise
- Biochemistry and Chemical Biology
- Cell Biology
- Chromosomes and Gene Expression
- Microbiology and Infectious Disease
- Physics of Living Systems
- Structural Biology and Molecular Biophysics
- Research focus
- single molecule biophysics
- microbiology
- cell division
- cell wall
- gene expression
- Experimental organism
- E. coli
-
María Mercedes Zambrano
CorpoGen, Colombia
- Expertise
- Microbiology and Infectious Disease
- Genetics and Genomics
- Research focus
- environmental microbiology
- microbial communities
- biodiversity
- microbiome
- antimicrobial resistance
- extreme environments